Investing Profile

Gaurav Aggarwal

InvestorVC
Managing Director at Vivo Capital
vivocapital.com/Team/gaurav-a...Menlo Park, California
Photo of Gaurav Aggarwal, Managing Director at Vivo Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Vivo Capital Managing Director
$10.0M - $50.0M
$25.0M
5
$1.4B
CompanyStageDateRound SizeTotal Raised
EpiBiologics
Series BJan 2026$110M
$200M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Alaa Halawa (Mubadala), Samuel Bjork (Digitalis Ventures), Nisa Leung (Qiming Venture Partners)
Serán Bioscience
Private EquitySep 2024$200M
$200M
Unicycive Therapeutics
Post Ipo EquityMar 2023$30M
$30M
Visirna Therapeutics
SeedApr 2022$60M
$60M
Co-investors: Hongbo Lu (Vivo Capital)
Auspex Pharmaceuticals
Series DNov 2012$25M
$25M